PHARMARESOURCES (SPHARMARESOURCES (SPHARMARESOURCES (S

PHARMARESOURCES (S

No trades
See on Supercharts

301230 fundamentals

PHARMARESOURCES (S financial statements, including revenue, expenses, profit, and loss

The total revenue of 301230 for the last quarter is 134.76 M CNY, and it's 3.50% higher compared to the previous quarter. The net income of Q2 24 is 12.31 M CNY.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth